Dietary supplement containing ED drug is recalled voluntarily

May 3, 2007

Cosmos Trading, Inc., is conducting a voluntary nationwide recall of its dietary supplement product sold under the name Rhino Max (Rhino V Max) after lab analysis found that the product contains aminotadalafil, an analogue of tadalafil, making Rhino Max (Rhino V Max) an unapproved drug.

Cosmos Trading, Inc., is conducting a voluntary nationwide recall of its dietary supplement product sold under the name Rhino Max (Rhino V Max) after lab analysis found that the product contains aminotadalafil, an analogue of tadalafil, making Rhino Max (Rhino V Max) an unapproved drug.

FDA advised that aminotadalafil may interact with nitrates found in prescription drugs for diabetes, hypertension, hyperlipidemia, and cardiovascular disease, and that it may lower blood pressure to dangerous levels. Men who have these medical conditions often have erectile dysfunction, and may ingest products such as Rhino Max to enhance sexual performance.

The current product label does not warn consumers who have high blood pressure not to ingest the product, and it does list aminotadalafil among active ingredients.